vs
Penumbra Inc（PEN）与GIBRALTAR INDUSTRIES, INC.（ROCK）财务数据对比。点击上方公司名可切换其他公司
Penumbra Inc的季度营收约是GIBRALTAR INDUSTRIES, INC.的1.7倍（$385.4M vs $225.0M），GIBRALTAR INDUSTRIES, INC.同比增速更快（24.9% vs 22.1%），Penumbra Inc自由现金流更多（$68.0M vs $26.2M），过去两年Penumbra Inc的营收复合增速更高（17.6% vs -12.3%）
Penumbra Inc是2004年由Arani Bose与Adam Elsesser联合创立的美国医疗器械企业，总部位于加利福尼亚州阿拉米达，核心业务为研发、生产中风、动脉瘤等血管疾病介入治疗所用的专业医疗设备，产品已在全球多个国家的临床诊疗场景中投入使用。
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
PEN vs ROCK — 直观对比
营收规模更大
PEN
是对方的1.7倍
$225.0M
营收增速更快
ROCK
高出2.8%
22.1%
自由现金流更多
PEN
多$41.8M
$26.2M
两年增速更快
PEN
近两年复合增速
-12.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $385.4M | $225.0M |
| 净利润 | $47.3M | — |
| 毛利率 | 68.0% | 25.3% |
| 营业利润率 | 15.4% | 7.9% |
| 净利率 | 12.3% | — |
| 营收同比 | 22.1% | 24.9% |
| 净利润同比 | 40.6% | — |
| 每股收益（稀释后） | $1.20 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PENROCK
| Q4 25 | $385.4M | $225.0M | ||
| Q3 25 | $354.7M | $310.9M | ||
| Q2 25 | $339.5M | $309.5M | ||
| Q1 25 | $324.1M | $290.0M | ||
| Q4 24 | $315.5M | $180.1M | ||
| Q3 24 | $301.0M | $277.1M | ||
| Q2 24 | $299.4M | $273.6M | ||
| Q1 24 | $278.7M | $292.5M |
净利润PENROCK
| Q4 25 | $47.3M | — | ||
| Q3 25 | $45.9M | $-89.1M | ||
| Q2 25 | $45.3M | $26.0M | ||
| Q1 25 | $39.2M | $21.1M | ||
| Q4 24 | $33.7M | — | ||
| Q3 24 | $29.5M | $34.0M | ||
| Q2 24 | $-60.2M | $32.2M | ||
| Q1 24 | $11.0M | $24.9M |
毛利率PENROCK
| Q4 25 | 68.0% | 25.3% | ||
| Q3 25 | 67.8% | 26.6% | ||
| Q2 25 | 66.0% | 28.4% | ||
| Q1 25 | 66.6% | 26.8% | ||
| Q4 24 | 66.8% | 29.0% | ||
| Q3 24 | 66.5% | 29.4% | ||
| Q2 24 | 54.4% | 30.5% | ||
| Q1 24 | 65.0% | 28.9% |
营业利润率PENROCK
| Q4 25 | 15.4% | 7.9% | ||
| Q3 25 | 13.8% | 12.8% | ||
| Q2 25 | 12.0% | 12.8% | ||
| Q1 25 | 12.4% | 8.8% | ||
| Q4 24 | 13.6% | 13.3% | ||
| Q3 24 | 11.7% | 15.6% | ||
| Q2 24 | -27.0% | 14.9% | ||
| Q1 24 | 4.3% | 10.8% |
净利率PENROCK
| Q4 25 | 12.3% | — | ||
| Q3 25 | 12.9% | -28.6% | ||
| Q2 25 | 13.3% | 8.4% | ||
| Q1 25 | 12.1% | 7.3% | ||
| Q4 24 | 10.7% | — | ||
| Q3 24 | 9.8% | 12.3% | ||
| Q2 24 | -20.1% | 11.8% | ||
| Q1 24 | 3.9% | 8.5% |
每股收益（稀释后）PENROCK
| Q4 25 | $1.20 | — | ||
| Q3 25 | $1.17 | $-2.98 | ||
| Q2 25 | $1.15 | $0.87 | ||
| Q1 25 | $1.00 | — | ||
| Q4 24 | $0.88 | — | ||
| Q3 24 | $0.75 | $1.11 | ||
| Q2 24 | $-1.55 | $1.05 | ||
| Q1 24 | $0.28 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $186.9M | $115.7M |
| 总债务越低越好 | — | $0 |
| 股东权益账面价值 | $1.4B | $950.4M |
| 总资产 | $1.8B | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资PENROCK
| Q4 25 | $186.9M | $115.7M | ||
| Q3 25 | $321.0M | $89.4M | ||
| Q2 25 | $421.8M | $43.3M | ||
| Q1 25 | $376.1M | $25.1M | ||
| Q4 24 | $324.4M | $269.5M | ||
| Q3 24 | $280.5M | $228.9M | ||
| Q2 24 | $288.3M | $179.1M | ||
| Q1 24 | $223.1M | $146.7M |
总债务PENROCK
| Q4 25 | — | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
股东权益PENROCK
| Q4 25 | $1.4B | $950.4M | ||
| Q3 25 | $1.4B | $951.8M | ||
| Q2 25 | $1.3B | $1.0B | ||
| Q1 25 | $1.2B | $1.0B | ||
| Q4 24 | $1.2B | $1.0B | ||
| Q3 24 | $1.1B | $1.0B | ||
| Q2 24 | $1.2B | $975.7M | ||
| Q1 24 | $1.2B | $940.2M |
总资产PENROCK
| Q4 25 | $1.8B | $1.4B | ||
| Q3 25 | $1.7B | $1.4B | ||
| Q2 25 | $1.7B | $1.5B | ||
| Q1 25 | $1.6B | $1.4B | ||
| Q4 24 | $1.5B | $1.4B | ||
| Q3 24 | $1.5B | $1.4B | ||
| Q2 24 | $1.5B | $1.4B | ||
| Q1 24 | $1.6B | $1.3B |
负债/权益比PENROCK
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $86.5M | $35.5M |
| 自由现金流经营现金流 - 资本支出 | $68.0M | $26.2M |
| 自由现金流率自由现金流/营收 | 17.7% | 11.7% |
| 资本支出强度资本支出/营收 | 4.8% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.83× | — |
| 过去12个月自由现金流最近4个季度 | $174.9M | $120.6M |
8季度趋势，按日历期对齐
经营现金流PENROCK
| Q4 25 | $86.5M | $35.5M | ||
| Q3 25 | $58.3M | $73.0M | ||
| Q2 25 | $44.9M | $44.9M | ||
| Q1 25 | $49.0M | $13.7M | ||
| Q4 24 | $51.1M | $19.9M | ||
| Q3 24 | $56.5M | $64.7M | ||
| Q2 24 | $22.6M | $36.5M | ||
| Q1 24 | $38.3M | $53.2M |
自由现金流PENROCK
| Q4 25 | $68.0M | $26.2M | ||
| Q3 25 | $42.0M | $64.8M | ||
| Q2 25 | $29.4M | $27.3M | ||
| Q1 25 | $35.5M | $2.3M | ||
| Q4 24 | $45.7M | $14.1M | ||
| Q3 24 | $51.0M | $60.5M | ||
| Q2 24 | $18.1M | $33.5M | ||
| Q1 24 | $32.5M | $48.8M |
自由现金流率PENROCK
| Q4 25 | 17.7% | 11.7% | ||
| Q3 25 | 11.8% | 20.8% | ||
| Q2 25 | 8.7% | 8.8% | ||
| Q1 25 | 11.0% | 0.8% | ||
| Q4 24 | 14.5% | 7.8% | ||
| Q3 24 | 16.9% | 21.8% | ||
| Q2 24 | 6.0% | 12.2% | ||
| Q1 24 | 11.7% | 16.7% |
资本支出强度PENROCK
| Q4 25 | 4.8% | 4.1% | ||
| Q3 25 | 4.6% | 2.6% | ||
| Q2 25 | 4.6% | 5.7% | ||
| Q1 25 | 4.2% | 3.9% | ||
| Q4 24 | 1.7% | 3.3% | ||
| Q3 24 | 1.8% | 1.5% | ||
| Q2 24 | 1.5% | 1.1% | ||
| Q1 24 | 2.1% | 1.5% |
现金转化率PENROCK
| Q4 25 | 1.83× | — | ||
| Q3 25 | 1.27× | — | ||
| Q2 25 | 0.99× | 1.73× | ||
| Q1 25 | 1.25× | 0.65× | ||
| Q4 24 | 1.52× | — | ||
| Q3 24 | 1.91× | 1.90× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | 3.48× | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PEN
| Thrombectomy | $254.7M | 66% |
| Other | $130.7M | 34% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
